Ridloff Elena

DirectorKronos Bio, Inc. (KRON) · full profile →Form 4 · filed Jun 20, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Tender(U)25K$0.57$14K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Disposed to issuer(D)17K$00
Jun 20, 2025Disposed to issuer(D)34K$00
Jun 20, 2025Disposed to issuer(D)15K$00
Jun 20, 2025Disposed to issuer(D)27K$00
Jun 20, 2025Disposed to issuer(D)26K$00
Jun 20, 2025Disposed to issuer(D)17K$00

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-017835) within minutes of acceptance. Every field above traces to the original document. Verify it directly: